NCT07080190

Brief Summary

This study aimed to determine the role of early urine alkalinization and N-acetylcysteine administration for the prevention of renal damage following hair dye intoxication

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
Last Updated

July 23, 2025

Status Verified

July 1, 2025

Enrollment Period

12 months

First QC Date

July 14, 2025

Last Update Submit

July 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean difference of the serum creatinine

    Mean difference of the serum creatinine was recorded.

    Immediately after N-Acetylcysteine Administration (Up to 1 hour)

Study Arms (2)

Study group

EXPERIMENTAL

Patients received early N-Acetylcysteine.

Drug: Early N-Acetylcysteine

Control group

ACTIVE COMPARATOR

Patients received late N-Acetylcysteine.

Drug: Late N-Acetylcysteine

Interventions

Patients received N-acetyl cysteine early (at admission) in the course of treatment of acute hair dye poisoning.

Study group

Patients received the standard treatment of N-acetyl cysteine after starting organ affection in the course of treatment of acute hair dye poisoning.

Control group

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Both sexes.
  • Patients presented acutely to the emergency department with an evident history and clinical features of hair dye intoxication

You may not qualify if:

  • Renal disease.
  • Hepatic disease.
  • Diabetes mellitus.
  • Hypertension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Valley university

Qina, 83523, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, South Valley University, Qena, Egypt.

Study Record Dates

First Submitted

July 14, 2025

First Posted

July 23, 2025

Study Start

July 1, 2022

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

July 23, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations